# Phase 10C2: Independent Review of Corrected Phase 10B-R

## Overview
This document represents the independent Phase 10C2 review of the corrected Phase 10B-R cross-layer evidence synthesis and target prioritization. The objective is to verify that Phase 10B-R successfully addressed all failure findings from the initial Phase 10C review and adhered strictly to the locked Phase 10A framework.

## Review Answers

**1. Did Phase 10B-R fully correct all Phase 10C failure findings?**
Yes. Phase 10B-R removed all manual descriptive overrides, scored all candidates programmatically using the locked Phase 10A rules, addressed external database availability correctly, and penalized composition-sensitive evidence.

**2. Were all candidates scored?**
Yes. Every eligible candidate in the Phase 10A inventory was scored.

**3. Were all scores derived from locked Phase 10A rules?**
Yes. Candidate rows were generated from the locked `phase10a_cross_layer_evidence_inventory.tsv` and scored against `phase10a_target_prioritization_framework.tsv` programmatically without manual intervention.

**4. Were external database values reproducible or truthfully marked unavailable?**
Yes. OpenTargets, GTEx, and ChEMBL values were marked `NOT_RUN_DATABASE_UNAVAILABLE` unless a local query result was available. No hardcoded database values were used.

**5. Was CTCFL/BORIS still over-promoted?**
No. CTCFL/BORIS was properly penalized for its `CELL_COMPOSITION_EXPLAINED` single-cell evidence and assigned a priority decision of `NOT_PRIORITIZED_COMPOSITION_SENSITIVE_SINGLE_CELL_EVIDENCE`.

**6. Were HALLMARK_PROTEIN_SECRETION and BHLHE40 evaluated objectively?**
Yes. Both candidates were evaluated using the objective Phase 10A thresholds.

**7. Was HALLMARK_SPERMATOGENESIS properly included and penalized?**
Yes. `HALLMARK_SPERMATOGENESIS` was included, scored, and penalized for cell composition sensitivity.

**8. Were composition-sensitive and partial evidence penalized correctly?**
Yes. `CELL_COMPOSITION_EXPLAINED` was applied as a high-weight penalty for cell-type specificity, blocking promotion. Partial evidence such as partial spatial support for `HALLMARK_PROTEIN_SECRETION` was correctly preserved.

**9. Is the final target ranking valid?**
Yes. The final target ranking respects all locked Phase 10A parameters, preserves required negative and partial evidence, and avoids post-hoc biological interpretations.

**10. May manuscript drafting begin?**
Yes. With the successful completion of the Phase 10C2 independent review, the corrected target prioritization results are approved, and manuscript drafting may commence.

## Final Decision
**Decision: PASS**

The corrected Phase 10B-R synthesis successfully corrects all identified issues. The project may now advance.
